UBS Group
IVDA icon

UBS Group’s Iveda Solutions IVDA Stock Holding History

UBS Group’s Portfolio IVDA Stock Details IVDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,659
Closed -$6.85K – 10734
2026
Q1 		$6.85K Buy
+26,659
New +$14.3K ﹤0.01% 8647
2025
Q4 		– Sell
-21
Closed -$28 – 10851
2025
Q3 		$28 Sell
21
-2,386
-99% -$4.3K ﹤0.01% 10086
2025
Q2 		$4.89K Sell
2,407
-9,197
-79% -$20.6K ﹤0.01% 9231
2025
Q1 		$26.2K Sell
11,604
-14,894
-56% -$48K ﹤0.01% 8036
2024
Q4 		$131K Buy
26,498
+21,296
+409% +$43.9K ﹤0.01% 6705
2024
Q3 		$8.69K Buy
5,202
+1,893
+57% +$5.87K ﹤0.01% 7824
2024
Q2 		$13.4K Buy
3,309
+1,375
+71% +$8.14K ﹤0.01% 7551
2024
Q1 		$13.9K Buy
1,934
+1,729
+843% +$10.2K ﹤0.01% 7083
2023
Q4 		$1.04K Sell
205
-424
-67% -$2.43K ﹤0.01% 8424
2023
Q3 		$4.31K Buy
+629
New +$4.83K ﹤0.01% 7455
2023
Q1 		– Sell
-220
Closed -$984 – 9963
2022
Q4 		$984 Sell
220
-587
-73% -$3.07K ﹤0.01% 10010
2022
Q3 		$4K Buy
807
+791
+4,944% +$6.98K ﹤0.01% 9364
2022
Q2 		$0 Buy
+16
New +$225 ﹤0.01% 10619

Other funds holding IVDA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group's IVDA Position: Q2 2026 in Review

UBS Group sold out of Iveda Solutions (IVDA) in Q2 2026, closing a stake of 26,659 shares — an estimated $6.85K sold.

UBS Group first reported a position in IVDA in Q2 2022 and held it in 13 quarters. The position peaked at $131K in Q4 2024. 12 funds tracked by Wall St. Rank hold IVDA as of Q2 2026.

  • UBS Group reported no remaining Iveda Solutions position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 26,659 Iveda Solutions shares in Q2 2026, an estimated $6.85K.
  • UBS Group first reported a position in Iveda Solutions in Q2 2022 and held it in 13 quarters.
  • UBS Group's Iveda Solutions position peaked at $131K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Iveda Solutions as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.